33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Histone 1 mutations drive lymphomagenesis by inducing primitive stem cell functions and epigenetic instructions through profound 3D re-organization of the B-cell genome
    Meeting Abstract

    Yusufova, N.; Teater, M. R.; Soshnev, A.; Kloetgen, A.; Osunsade, A.; Conway, J.; Doane, A.; Skoultchi, A.; Tsirigos, A.; David, Y.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Ibrutinib and rituximab provides superior clinical outcome compared to FCR in younger patients with chronic lymphocytic leukemia (CLL): Extended follow-up from the E1912 trial
    Meeting Abstract

    Shanafelt, T. D.; Wang, V.; Kay, N. E.; Hanson, C. A.; O'Brien, S. M.; Barrientos, J. C.; Jelinek, D. F.; Braggio, E.; Leis, J. F.; Zhang, C. C.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • The Disease-Risk Stratification Scheme (DRSS), a contemporary risk-stratification system for allogeneic stem cell transplantation
    Meeting Abstract

    Shouval, R.; Fein, J. A.; Labopin, M.; Bazarbachi, A.; Baron, F.; Bug, G.; Ciceri, F.; Corbacioglu, S.; Giebel, S.; Gilleece, M. H.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Genetic alterations at diagnosis predict outcome of AML patients age 60 or older undergoing allogeneic transplantation in first remission
    Meeting Abstract

    Murdock, H. M.; Kim, H. T.; Hambley, B.; Vachhani, P.; Denlinger, N.; Gier, S. H.; Cho, C.; Perales, M. A.; Koreth, J.; Ho, V. T.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Genomic profiling of mantle cell lymphoma suggests poor-risk profile is present at diagnosis and does not arise by tumor evolution
    Meeting Abstract

    Joffe, E.; Kumar, A.; Zheng, S.; Uppal, M.; Bantilan, K. S.; Atteberry, P.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy
    Meeting Abstract

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Famulare, C.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z. D.; Menghrajani, K.; Glass, J. L.; Taylor, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Synthetic antibody phage libraries as tools for generating antibodies against difficult analytes
    Meeting Abstract

    Sanmark, H.; Perez, S.; Leivo, J.; Kivimäki, L.; Batra, G.; Lilja, H.; Lamminmäki, U.
    Clinica Chimica Acta (2019)

    Fulltext@MSK | Save
  • Developing a cancer-specific trigger tool to identify adverse events using administrative data
    Meeting Abstract

    Weingart, S. N.; Koethe, B.; Nelson, J.; Yaghi, O.; Kent, D. M.; Hassett, M. J.; Lipitz-Snyderman, A.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Comparison of attitudes and beliefs about cancer clinical trial enrollment between physicians, research staff, and cancer patients
    Meeting Abstract

    Hillyer, G.; Beauchemin, M.; Hershman, D. L.; Kelsen, M. A.; Brogan, F. L.; Sandoval, R.; Schmitt, K. M.; Reyes, A.; Terry, M. B.; Lassman, A. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Adherence to breast cancer treatment guidelines according to pathogenic variants in cancer susceptibility genes in a population-based cohort
    Meeting Abstract

    Katz, S. J.; Morrow, M.; Kurian, A. W.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save